Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 8—August 2012
Letter

Epidemic Clostridium difficile Ribotype 027 in Chile

Cristian Hernández-Rocha1, Jonathan Barra-Carrasco1, Marjorie Pizarro-Guajardo, Patricio Ibáñez, Susan M. Bueno, Mahfuzur R. Sarker, Ana María Guzman, Manuel Álvarez-Lobos, and Daniel Paredes-SabjaComments to Author 
Author affiliations: Pontificia Universidad Católica de Chile, Santiago, Chile (C. Hernández-Rocha, P. Ibáñez, S.M. Bueno, A.M. Guzman, M. Álvarez-Lobos); Universidad Andrés Bello, Santiago (J. Barra-Carrasco, M. Pizarro-Guajardo, D. Pareses-Sabja); and Oregon State University, Corvallis, Oregon, USA (M.R. Sarker, D. Paredes-Sabja)

Main Article

Figure

Results of PCR ribotyping of Clostridium difficile 027 strains from Chile. M indicates the 100-bp DNA ladder; lane 2, R20291; lane 2, PUC47; lane 3, PUC51. A) PCR ribotyping of C. difficile isolates. PCR results show that that the band pattern of the ribosomal intergenic regions of strains PUC47 and PUC51 are similar to those of the reference (epidemic) strain R20291. B) Cluster analysis of strains PUC47, PUC51, and the epidemic strain 027 R20291 shows >99% similarity and that they belong to

Figure. . Results of PCR ribotyping of Clostridium difficile 027 strains from Chile. M indicates the 100-bp DNA ladder; lane 2, R20291; lane 2, PUC47; lane 3, PUC51. A) PCR ribotyping of C. difficile isolates. PCR results show that that the band pattern of the ribosomal intergenic regions of strains PUC47 and PUC51 are similar to those of the reference (epidemic) strain R20291. B) Cluster analysis of strains PUC47, PUC51, and the epidemic strain 027 R20291 shows >99% similarity and that they belong to the same epidemic clade. Scale bar indicates percent identity.

Main Article

1These authors contributed equally to this article.

Page created: July 20, 2012
Page updated: July 20, 2012
Page reviewed: July 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external